Enjoy Technology, Led by Ex-Apple Executive Ron Johnson, Files for Chapter 11 to Sell Itself

The tech retailer that showcased home delivery and service was started by Mr. Johnson, who pioneered Apple's Genius Bar, but later slipped as chief of J.C. Penney

 
Leon Black's Conspiracy Complaint Against Apollo Co-Founder Is Dismissed

The private-equity firm's former chief executive had accused Josh Harris of encouraging a woman to come forward with claims of rape and harassment.

 
If JetBlue Needs Spirit Airlines This Badly, It Must Fear Life Alone

JetBlue's willingness to pay a hefty premium for low-cost carrier Spirit Airlines is being punished by investors, with some wondering what it suggests about JetBlue's place in a future of high costs.

 
Beer Demand Lifts Corona Maker's Sales

Constellation Brands said quarterly sales grew by almost 17%, with strong demand for Modelo and Corona beers helping offset rising costs, and said its board has agreed to a plan reducing the Sands family's voting power.

 
Startup Founders Say Venture-Capital Investors Are Driving Harder Deals

Startup founders say venture-capital investors are offering tougher terms as companies attempt to raise money amid economic uncertainty and a broad selloff in tech stocks.

 
Unity Software Lays Off Around 4% of Workforce

The maker of tools for creating mobile games and other applications is the latest tech company to turn cautious about staffing.

 
Drugmaker Endo Skips Interest Payment Amid Debt Talks

The drug producer is in discussions with creditors as it faces an earnings drop and thousands of opioid-related lawsuits.

 
RH Cuts Financial Targets, as Furniture Retailers Face Slower Consumer Spending

RH, formerly Restoration Hardware, is the latest furniture seller to brace for a sharp slowdown in sales, as mortgage rates rise and consumers pull back spending on sofas, beds and other furnishings.

 
Walgreens Profit Shrinks After Opioid Deal, Fewer Vaccinations

The drugstore chain said its quarterly sales fell and earnings plunged as revenue from Covid-19 vaccinations dried up. It also paid out a $683 million opioid settlement.

 
Pfizer Asks FDA to Fully Approve Its Covid-19 Pill

Approval of Paxlovid, which has been available under an Food and Drug Administration authorization for use during the pandemic, would allow Pfizer to market and sell it commercially.

(END) Dow Jones Newswires

June 30, 2022 15:00 ET (19:00 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.